New Drugs for Rheumatoid Arthritis | NEJM
Frontiers | Use of TNF Inhibitors in Rheumatoid Arthritis and Implications for the Periodontal Status: For the Benefit of Both?
Novel therapeutic targets in rheumatoid arthritis: Trends in Pharmacological Sciences
Defining response to TNF-inhibitors in rheumatoid arthritis: the negative impact of anti-TNF cycling and the need for a personalized medicine approach to identify primary non-responders | SpringerLink
Frontiers | Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications
Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls | Immunotherapy
Golimumab Therapy of Rheumatoid Arthritis: An Overview - Zidi - 2010 - Scandinavian Journal of Immunology - Wiley Online Library
Molecular mechanisms of action of anti-TNF-α agents – Comparison among therapeutic TNF-α antagonists - ScienceDirect
JPM | Free Full-Text | Using the Immunophenotype to Predict Response to Biologic Drugs in Rheumatoid Arthritis
Adalimumab Rambhia KD, Khopkar US - Indian J Drugs Dermatol
Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases
UPDATE: FDA rejects Sanofi's promising Rheumatoid Arthritis Drug
In vitro Cell-Based Assays for Potency Testing of Anti-TNF-α Biological Drugs | IntechOpen
Frontiers | Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis
![rheumatoid_arthritis [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/raeffects.png "rheumatoid_arthritis [TUSOM | Pharmwiki]")
rheumatoid_arthritis [TUSOM | Pharmwiki]
Treatment of Rheumatoid Arthritis with Biological Agents | IntechOpen
Anti-TNF-α therapies: the next generation | Nature Reviews Drug Discovery
Development of anti-TNF therapy for rheumatoid arthritis | Nature Reviews Immunology
Frontiers | Targeting TNF-α for COVID-19: Recent Advanced and Controversies
Schematic of TNF inhibitors and their mode of action. Receptor (i.e.... | Download Scientific Diagram
Immunogenicity and loss of response to TNF inhibitors: implications for rheumatoid arthritis treatment | Nature Reviews Rheumatology
Role of biological agents in treatment of rheumatoid arthritis - ScienceDirect
Current immunotherapy in rheumatoid arthritis | Immunotherapy
